DiaSorin: Established Player in Infectious Diseases Expanding Into Molecular Diagnostics

DiaSorin is a niche player in the fragmented in vitro diagnostic, or IVD, market with specialization in infectious diseases. Its systems can perform tests for a wide range of diseases including hepatitis, tuberculosis, mumps, and measles. Despite operating in a competitive industry with high research and investment requirements, DiaSorin has consistently been able to expand its installed base and deliver strong returns for shareholders over time. The company also benefited from the covid pandemic with a higher installed base and a greater awareness of the importance of IVD testing for respiratory infections.